Immatics at SITC (Nov 7-11) in Washington, DC

| News, USA

We're happy to announce, that Immatics will be part of the SITC Conference in Washington, DC (Nov 7-11). If you're there, stop by and discuss with our experts newest trial results and scientific insights:

 

November 10th, 12:20pm-1:50pm and 7:00pm-8:30pm

Poster: "The GAPVAC approach of actively personalized peptide vaccination for patients with newly diagnosed glioblastoma." (Abstract Poster #O8)

Presenter: Norbert Hilf (Vice President Translational Development)

 

Poster: "Targeting novel tumor-associated antigens with TCR-engineered T Cells" (Abstract Poster #P246)

Presenter: Mamta Kalra (Associate Director CMC, Immatics US)

 

In addition, the GAPVAC approach will also be presented in a talk by Hideho Okada (UCSF):

November 9th, 3:00pm-3:15pm

"The GAPVAC approach of actively personalized peptide vaccination for patients with newly diagnosed glioblastoma"

Speaker: Hideho Okada (University of California, San Francisco, USA and Parker Institute for Cancer Immunotherapy)

Session: "Early Phase 1 Clinical Trials"

 

We're looking forward to interesting and exciting discussions.

Further information about SITC here.

Further information about GAPVAC here.

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back